VIVUS Press Releases

Date Title Links
Toggle Summary VIVUS Reports 2005 Fourth Quarter and Full-Year Financial Results
Multiple Late-Stage Product Candidates Continue to Meet Key Development Milestones
View HTML
Toggle Summary VIVUS Announces Fourth Quarter and Full Year 2005 Financial Results Conference Call
VIVUS Announces Fourth Quarter and Full Year 2005 Financial Results Conference Call Feb 16, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS), a leading specialty pharmaceutical company focused on the development and commercialization of novel therapeutics to restore
View HTML
Toggle Summary VIVUS to Present at BIO CEO & Investor Conference
VIVUS to Present at BIO CEO & Investor Conference MOUNTAIN VIEW, Calif., Feb. 10 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a leading specialty pharmaceutical company focused on the development and commercialization of novel products to restore sexual function in women and men, today
View HTML
Toggle Summary VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
EvaMist(TM) is an Investigational Drug for the Treatment of Menopausal Symptoms
View HTML